Alison Boudreaux, MD
Dermatology · Sacramento, CANPI 1093782120
Payments from drug & device makers
Across 743 payments — averaging $53.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$27K
- Sun Pharmaceutical Industries Inc.$1K
- Lilly USA, LLC$1K
- Novartis$985
- Pfizer$933
- Johnson & Johnson$696
- plus $7K from 30 others
What the payments were for
- Consulting fees$1,8005%
- Speaking & faculty fees$19,44249%
- Travel & lodging$1,1303%
- Food & beverage$16,83443%
- Education$1700%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 247 | $26,848 |
| Sun Pharmaceutical Industries Inc. | 58 | $1,308 |
| Lilly USA, LLC | 48 | $1,234 |
| Novartis | 64 | $985 |
| Pfizer | 37 | $933 |
| Johnson & Johnson | 37 | $696 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 25 | $687 |
| LEO Pharma Inc. | 22 | $620 |
| Regeneron Healthcare Solutions, Inc. | 25 | $618 |
| E.r. Squibb & Sons, L.L.C. | 18 | $603 |
| Incyte Corporation | 19 | $575 |
| Galderma Laboratories, L.p. | 24 | $508 |
| Sanofi | 15 | $393 |
| UCB, Inc. | 14 | $374 |
| Dermavant Sciences, Inc. | 11 | $370 |
| Revance Therapeutics, Inc. | 15 | $360 |
| Amgen | 11 | $318 |
| Merz North America, Inc. | 5 | $244 |
| Genentech USA, Inc. | 4 | $194 |
| Arcutis Biotherapeutics, Inc. | 4 | $193 |
| Biofrontera Inc. | 9 | $184 |
| DUSA Pharmaceuticals, Inc. | 3 | $171 |
| Almirall LLC | 8 | $156 |
| Boehringer Ingelheim | 2 | $155 |
| Janssen Scientific Affairs, LLC | 1 | $123 |
| EPI Health, LLC | 1 | $92 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $78 |
| Verrica Pharmaceuticals Inc. | 3 | $62 |
| Mayne Pharma Commercial LLC | 2 | $61 |
| Stemline Therapeutics Inc. | 1 | $57 |
| Botanix SB Inc | 3 | $47 |
| Organon | 2 | $44 |
| Dermira, Inc. | 1 | $26 |
| Organogenesis Inc. | 1 | $24 |
| Polynovo North America LLC | 1 | $18 |
| LNHC, Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$39,376 in reported general payments places this provider in the 85th percentile of 1,875 dermatology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 23 | $94,676 |
| Doxycycline Hyclate | 75 | $5,405 |
| Clobetasol Propionate | 99 | $4,704 |
| Fluorouracil | 48 | $2,919 |
| ValacyclovirValacyclovir Hcl | 26 | $1,430 |
| Ketoconazole | 58 | $1,325 |
| Desonide | 22 | $861 |
| Hydroxychloroquine Sulfate | 11 | $756 |
| Minoxidil | 59 | $696 |
| Triamcinolone Acetonide | 47 | $322 |
| Terbinafine Hcl | 15 | $232 |
| Finasteride | 25 | $202 |
| Mometasone Furoate | 12 | $176 |
| Cephalexin | 11 | $170 |
| Nystatin | 11 | $164 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Sacramento
- Raja SivamaniSacramento$11.8M
- Emanual MaverakisSacramento$3.5M
- Jennifer OrnelasSacramento$1.3M
- Emil TanghettiSacramento$1.2M
- Stephanie leSacramento$1.1M
- Vivian LaquerIrvine$20.9M
- Howard SofenLos Angeles$16.1M
- Jennifer SoungSanta Ana$10.3M
- Stacy SmithEncinitas$7.9M
- Paul YamauchiSanta Monica$7.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.